Compare Cenovus Energy Inc (CVE) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cenovus Energy Inc vs Tempus AI — how do they compare? Cenovus Energy Inc trades at $31.49 (market cap $56.66B), while Tempus AI trades at $69.99 (market cap $12.77B). The key difference: Cenovus Energy Inc is far larger — about 4.4× Tempus AI's market cap, and Cenovus Energy Inc pays a 2.03% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cenovus Energy Inc for 46 Days and Tempus AI for 22 Days on average.
| CVE | TEM | |
|---|---|---|
Market Cap | $56.66B | $12.77B |
Volume | 7,667,753 | 8,980,490 |
Sector | Energy | Broad Market / Factor |
52-Week High | $33.92 | $99.28 |
52-Week Low | $15.85 | $41.55 |
Typical Hold Time | 46 Days | 22 Days |
Enterprise Value | $62.61B | $13.40B |
Dividend Yield | 2.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cenovus Energy (CVE) trades at $31.49, up 0.8% today, with a bearish technical signal but strong fundamentals including a P/E of 12.14 and net income margin of 11.48%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q2 2026 met estimates. Cash flow from operations remains robust at $8.23B in 2025, though net cash flow was negative due to high capital expenditures. The stock is near its pivot point of $31, with support at $30 and resistance at $32.
Outlook: CVE offers value with attractive valuation ratios and solid profitability, but faces headwinds from volatile oil prices and capital-intensive operations. Analyst consensus is mixed with 40.7% buy ratings, suggesting cautious optimism amid energy sector uncertainty.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
